International Goldfields Ltd (ASX:IGS) is pleased to provide an update about Winter Garden Biosciences ("Winter Garden" or "WG") operational plans for 2015/2016. WG is a Uruguayan biosciences and pharmaceutical company in which IGS has agreed to acquire an 85% interest.
PhytoTech Medical Limited (ASX:PYL) (the ‘Company’) today announces a favourable addition to its licensing and collaboration agreement with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd (‘Yissum’).
PhytoTech Medical Limited (ASX:PYL) (the "Company") advises that it has released an updated investor presentation on the proposed merger with MMJ Bioscience Inc on its website at www.phytotechmed.com/investor-presentation.
PhytoTech Medical Limited (ASX:PYL) is pleased to report that MMJ has received from Health Canada a "confirmation of readiness letter" that precedes the scheduling of a pre-licensing inspection.
PhytoTech Medical Limited (ASX:PYL) advises that BBY Limited initiated research on the Company on 19 March 2015 and has issued an updated research report dated 25 March 2015 in response to the Company's proposed merger with MMJ Bioscience Inc.
PhytoTech Medical Limited (ASX:PYL), the Australian listed Medical Cannabis (MC) company, is pleased to announce that it has entered into an agreement to acquire 100% of the issued capital of MMJ Bioscience Inc. (MMJ), a Canadian based multinational vertically integrated MC company.
PhytoTech Medical Limited (ASX:PYL) is focused on the research and development of products for administering MGC, and new treatments utilising MGC therapeutic components for various medical conditions.
